img

Global Metabotropic Glutamate Receptor 5 Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Metabotropic Glutamate Receptor 5 Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Metabotropic Glutamate Receptor 5 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Metabotropic Glutamate Receptor 5 is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Metabotropic Glutamate Receptor 5 is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Metabotropic Glutamate Receptor 5 is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Metabotropic Glutamate Receptor 5 include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, Eisai Co Ltd, Eli Lilly and Company, Heptares Therapeutics Ltd, Johnson & Johnson, Merz Pharma GmbH & Co KgaA and Novartis AG, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Metabotropic Glutamate Receptor 5, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Metabotropic Glutamate Receptor 5 by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Metabotropic Glutamate Receptor 5 market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Metabotropic Glutamate Receptor 5 market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc
By Type
Alloswitch-1
BMS-952048
BMS-955829
Dipraglurant ER
Others
By Application
Major Depressive Disorder
Alcohol Addiction
Alzheimer's Disease
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Metabotropic Glutamate Receptor 5 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Metabotropic Glutamate Receptor 5 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metabotropic Glutamate Receptor 5 sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Metabotropic Glutamate Receptor 5 Definition
1.2 Market by Type
1.2.1 Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Alloswitch-1
1.2.3 BMS-952048
1.2.4 BMS-955829
1.2.5 Dipraglurant ER
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Major Depressive Disorder
1.3.3 Alcohol Addiction
1.3.4 Alzheimer's Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Metabotropic Glutamate Receptor 5 Sales
2.1 Global Metabotropic Glutamate Receptor 5 Revenue Estimates and Forecasts 2018-2034
2.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Metabotropic Glutamate Receptor 5 Revenue by Region
2.3.1 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2018-2023)
2.3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2024-2034)
2.4 Global Metabotropic Glutamate Receptor 5 Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Metabotropic Glutamate Receptor 5 Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Metabotropic Glutamate Receptor 5 Sales Quantity by Region
2.6.1 Global Metabotropic Glutamate Receptor 5 Sales Quantity by Region (2018-2023)
2.6.2 Global Metabotropic Glutamate Receptor 5 Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Metabotropic Glutamate Receptor 5 Sales Quantity by Manufacturers
3.1.1 Global Metabotropic Glutamate Receptor 5 Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Metabotropic Glutamate Receptor 5 Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 5 Sales in 2024
3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers
3.2.1 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2018-2023)
3.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Metabotropic Glutamate Receptor 5 Revenue in 2024
3.3 Global Metabotropic Glutamate Receptor 5 Sales Price by Manufacturers
3.4 Global Key Players of Metabotropic Glutamate Receptor 5, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Metabotropic Glutamate Receptor 5, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Metabotropic Glutamate Receptor 5, Product Offered and Application
3.8 Global Key Manufacturers of Metabotropic Glutamate Receptor 5, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Metabotropic Glutamate Receptor 5 Sales Quantity by Type
4.1.1 Global Metabotropic Glutamate Receptor 5 Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Metabotropic Glutamate Receptor 5 Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Type (2018-2034)
4.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type
4.2.1 Global Metabotropic Glutamate Receptor 5 Historical Revenue by Type (2018-2023)
4.2.2 Global Metabotropic Glutamate Receptor 5 Forecasted Revenue by Type (2024-2034)
4.2.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2018-2034)
4.3 Global Metabotropic Glutamate Receptor 5 Price by Type
4.3.1 Global Metabotropic Glutamate Receptor 5 Price by Type (2018-2023)
4.3.2 Global Metabotropic Glutamate Receptor 5 Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Metabotropic Glutamate Receptor 5 Sales Quantity by Application
5.1.1 Global Metabotropic Glutamate Receptor 5 Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Metabotropic Glutamate Receptor 5 Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Application (2018-2034)
5.2 Global Metabotropic Glutamate Receptor 5 Revenue by Application
5.2.1 Global Metabotropic Glutamate Receptor 5 Historical Revenue by Application (2018-2023)
5.2.2 Global Metabotropic Glutamate Receptor 5 Forecasted Revenue by Application (2024-2034)
5.2.3 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2018-2034)
5.3 Global Metabotropic Glutamate Receptor 5 Price by Application
5.3.1 Global Metabotropic Glutamate Receptor 5 Price by Application (2018-2023)
5.3.2 Global Metabotropic Glutamate Receptor 5 Price Forecast by Application (2024-2034)
6 North America
6.1 North America Metabotropic Glutamate Receptor 5 Sales by Company
6.1.1 North America Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023)
6.1.2 North America Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023)
6.2 North America Metabotropic Glutamate Receptor 5 Market Size by Type
6.2.1 North America Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2034)
6.2.2 North America Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2034)
6.3 North America Metabotropic Glutamate Receptor 5 Market Size by Application
6.3.1 North America Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2034)
6.3.2 North America Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2034)
6.4 North America Metabotropic Glutamate Receptor 5 Market Size by Country
6.4.1 North America Metabotropic Glutamate Receptor 5 Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Metabotropic Glutamate Receptor 5 Revenue by Country (2018-2034)
6.4.3 North America Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Metabotropic Glutamate Receptor 5 Sales by Company
7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023)
7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023)
7.2 Europe Metabotropic Glutamate Receptor 5 Market Size by Type
7.2.1 Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2034)
7.2.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2034)
7.3 Europe Metabotropic Glutamate Receptor 5 Market Size by Application
7.3.1 Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2034)
7.3.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2034)
7.4 Europe Metabotropic Glutamate Receptor 5 Market Size by Country
7.4.1 Europe Metabotropic Glutamate Receptor 5 Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2018-2034)
7.4.3 Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Metabotropic Glutamate Receptor 5 Sales by Company
8.1.1 China Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023)
8.1.2 China Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023)
8.2 China Metabotropic Glutamate Receptor 5 Market Size by Type
8.2.1 China Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2034)
8.2.2 China Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2034)
8.3 China Metabotropic Glutamate Receptor 5 Market Size by Application
8.3.1 China Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2034)
8.3.2 China Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Metabotropic Glutamate Receptor 5 Sales by Company
9.1.1 APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023)
9.1.2 APAC Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023)
9.2 APAC Metabotropic Glutamate Receptor 5 Market Size by Type
9.2.1 APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2034)
9.2.2 APAC Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2034)
9.3 APAC Metabotropic Glutamate Receptor 5 Market Size by Application
9.3.1 APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2034)
9.3.2 APAC Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2034)
9.4 APAC Metabotropic Glutamate Receptor 5 Market Size by Region
9.4.1 APAC Metabotropic Glutamate Receptor 5 Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2018-2034)
9.4.3 APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales by Company
10.1.1 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Market Size by Type
10.2.1 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Market Size by Application
10.3.1 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Market Size by Country
10.4.1 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Addex Therapeutics Ltd
11.1.1 Addex Therapeutics Ltd Company Information
11.1.2 Addex Therapeutics Ltd Overview
11.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products and Services
11.1.5 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 SWOT Analysis
11.1.6 Addex Therapeutics Ltd Recent Developments
11.2 Aevi Genomic Medicine Inc
11.2.1 Aevi Genomic Medicine Inc Company Information
11.2.2 Aevi Genomic Medicine Inc Overview
11.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Products and Services
11.2.5 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 SWOT Analysis
11.2.6 Aevi Genomic Medicine Inc Recent Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Information
11.3.2 Bristol-Myers Squibb Company Overview
11.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Products and Services
11.3.5 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 SWOT Analysis
11.3.6 Bristol-Myers Squibb Company Recent Developments
11.4 Eisai Co Ltd
11.4.1 Eisai Co Ltd Company Information
11.4.2 Eisai Co Ltd Overview
11.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Products and Services
11.4.5 Eisai Co Ltd Metabotropic Glutamate Receptor 5 SWOT Analysis
11.4.6 Eisai Co Ltd Recent Developments
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Information
11.5.2 Eli Lilly and Company Overview
11.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Products and Services
11.5.5 Eli Lilly and Company Metabotropic Glutamate Receptor 5 SWOT Analysis
11.5.6 Eli Lilly and Company Recent Developments
11.6 Heptares Therapeutics Ltd
11.6.1 Heptares Therapeutics Ltd Company Information
11.6.2 Heptares Therapeutics Ltd Overview
11.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Products and Services
11.6.5 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 SWOT Analysis
11.6.6 Heptares Therapeutics Ltd Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Products and Services
11.7.5 Johnson & Johnson Metabotropic Glutamate Receptor 5 SWOT Analysis
11.7.6 Johnson & Johnson Recent Developments
11.8 Merz Pharma GmbH & Co KgaA
11.8.1 Merz Pharma GmbH & Co KgaA Company Information
11.8.2 Merz Pharma GmbH & Co KgaA Overview
11.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Products and Services
11.8.5 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 SWOT Analysis
11.8.6 Merz Pharma GmbH & Co KgaA Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Information
11.9.2 Novartis AG Overview
11.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Novartis AG Metabotropic Glutamate Receptor 5 Products and Services
11.9.5 Novartis AG Metabotropic Glutamate Receptor 5 SWOT Analysis
11.9.6 Novartis AG Recent Developments
11.10 Richter Gedeon Nyrt
11.10.1 Richter Gedeon Nyrt Company Information
11.10.2 Richter Gedeon Nyrt Overview
11.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Products and Services
11.10.5 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 SWOT Analysis
11.10.6 Richter Gedeon Nyrt Recent Developments
11.11 Sumitomo Dainippon Pharma Co Ltd
11.11.1 Sumitomo Dainippon Pharma Co Ltd Company Information
11.11.2 Sumitomo Dainippon Pharma Co Ltd Overview
11.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Products and Services
11.11.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
11.12 Toray Industries Inc
11.12.1 Toray Industries Inc Company Information
11.12.2 Toray Industries Inc Overview
11.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Products and Services
11.12.5 Toray Industries Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Metabotropic Glutamate Receptor 5 Value Chain Analysis
12.2 Metabotropic Glutamate Receptor 5 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metabotropic Glutamate Receptor 5 Production Mode & Process
12.4 Metabotropic Glutamate Receptor 5 Sales and Marketing
12.4.1 Metabotropic Glutamate Receptor 5 Sales Channels
12.4.2 Metabotropic Glutamate Receptor 5 Distributors
12.5 Metabotropic Glutamate Receptor 5 Customers
13 Market Dynamics
13.1 Metabotropic Glutamate Receptor 5 Industry Trends
13.2 Metabotropic Glutamate Receptor 5 Market Drivers
13.3 Metabotropic Glutamate Receptor 5 Market Challenges
13.4 Metabotropic Glutamate Receptor 5 Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Alloswitch-1
Table 3. Major Manufacturers of BMS-952048
Table 4. Major Manufacturers of BMS-955829
Table 5. Major Manufacturers of Dipraglurant ER
Table 6. Major Manufacturers of Others
Table 7. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Metabotropic Glutamate Receptor 5 Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2018-2023)
Table 11. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2024-2034)
Table 13. Global Metabotropic Glutamate Receptor 5 Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Metabotropic Glutamate Receptor 5 Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2018-2023)
Table 16. Global Metabotropic Glutamate Receptor 5 Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2024-2034)
Table 18. Global Metabotropic Glutamate Receptor 5 Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Metabotropic Glutamate Receptor 5 Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Metabotropic Glutamate Receptor 5 Revenue Share by Manufacturers (2018-2023)
Table 22. Global Metabotropic Glutamate Receptor 5 Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Metabotropic Glutamate Receptor 5, Industry Ranking, 2021 VS 2024
Table 24. Global Metabotropic Glutamate Receptor 5 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Metabotropic Glutamate Receptor 5 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabotropic Glutamate Receptor 5 as of 2024)
Table 26. Global Key Manufacturers of Metabotropic Glutamate Receptor 5, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Metabotropic Glutamate Receptor 5, Product Offered and Application
Table 28. Global Key Manufacturers of Metabotropic Glutamate Receptor 5, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Metabotropic Glutamate Receptor 5 Sales Quantity Share by Type (2018-2023)
Table 33. Global Metabotropic Glutamate Receptor 5 Sales Quantity Share by Type (2024-2034)
Table 34. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Metabotropic Glutamate Receptor 5 Revenue Share by Type (2018-2023)
Table 37. Global Metabotropic Glutamate Receptor 5 Revenue Share by Type (2024-2034)
Table 38. Metabotropic Glutamate Receptor 5 Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Metabotropic Glutamate Receptor 5 Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Metabotropic Glutamate Receptor 5 Sales Quantity Share by Application (2018-2023)
Table 43. Global Metabotropic Glutamate Receptor 5 Sales Quantity Share by Application (2024-2034)
Table 44. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Metabotropic Glutamate Receptor 5 Revenue Share by Application (2018-2023)
Table 47. Global Metabotropic Glutamate Receptor 5 Revenue Share by Application (2024-2034)
Table 48. Metabotropic Glutamate Receptor 5 Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Metabotropic Glutamate Receptor 5 Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Metabotropic Glutamate Receptor 5 Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Metabotropic Glutamate Receptor 5 Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Metabotropic Glutamate Receptor 5 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Metabotropic Glutamate Receptor 5 Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Metabotropic Glutamate Receptor 5 Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Metabotropic Glutamate Receptor 5 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Metabotropic Glutamate Receptor 5 Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Metabotropic Glutamate Receptor 5 Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Metabotropic Glutamate Receptor 5 Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Metabotropic Glutamate Receptor 5 Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Metabotropic Glutamate Receptor 5 Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Metabotropic Glutamate Receptor 5 Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. Addex Therapeutics Ltd Company Information
Table 121. Addex Therapeutics Ltd Description and Overview
Table 122. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Services
Table 124. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 125. Addex Therapeutics Ltd Recent Developments
Table 126. Aevi Genomic Medicine Inc Company Information
Table 127. Aevi Genomic Medicine Inc Description and Overview
Table 128. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product and Services
Table 130. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 131. Aevi Genomic Medicine Inc Recent Developments
Table 132. Bristol-Myers Squibb Company Company Information
Table 133. Bristol-Myers Squibb Company Description and Overview
Table 134. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product and Services
Table 136. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 137. Bristol-Myers Squibb Company Recent Developments
Table 138. Eisai Co Ltd Company Information
Table 139. Eisai Co Ltd Description and Overview
Table 140. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product and Services
Table 142. Eisai Co Ltd Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 143. Eisai Co Ltd Recent Developments
Table 144. Eli Lilly and Company Company Information
Table 145. Eli Lilly and Company Description and Overview
Table 146. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product and Services
Table 148. Eli Lilly and Company Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 149. Eli Lilly and Company Recent Developments
Table 150. Heptares Therapeutics Ltd Company Information
Table 151. Heptares Therapeutics Ltd Description and Overview
Table 152. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Services
Table 154. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 155. Heptares Therapeutics Ltd Recent Developments
Table 156. Johnson & Johnson Company Information
Table 157. Johnson & Johnson Description and Overview
Table 158. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 159. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product and Services
Table 160. Johnson & Johnson Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 161. Johnson & Johnson Recent Developments
Table 162. Merz Pharma GmbH & Co KgaA Company Information
Table 163. Merz Pharma GmbH & Co KgaA Description and Overview
Table 164. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 165. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product and Services
Table 166. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 167. Merz Pharma GmbH & Co KgaA Recent Developments
Table 168. Novartis AG Company Information
Table 169. Novartis AG Description and Overview
Table 170. Novartis AG Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 171. Novartis AG Metabotropic Glutamate Receptor 5 Product and Services
Table 172. Novartis AG Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 173. Novartis AG Recent Developments
Table 174. Richter Gedeon Nyrt Company Information
Table 175. Richter Gedeon Nyrt Description and Overview
Table 176. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 177. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product and Services
Table 178. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 SWOT Analysis
Table 179. Richter Gedeon Nyrt Recent Developments
Table 180. Sumitomo Dainippon Pharma Co Ltd Company Information
Table 181. Sumitomo Dainippon Pharma Co Ltd Description and Overview
Table 182. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 183. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product and Services
Table 184. Sumitomo Dainippon Pharma Co Ltd Recent Developments
Table 185. Toray Industries Inc Company Information
Table 186. Toray Industries Inc Description and Overview
Table 187. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 188. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product and Services
Table 189. Toray Industries Inc Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Metabotropic Glutamate Receptor 5 Distributors List
Table 193. Metabotropic Glutamate Receptor 5 Customers List
Table 194. Metabotropic Glutamate Receptor 5 Market Trends
Table 195. Metabotropic Glutamate Receptor 5 Market Drivers
Table 196. Metabotropic Glutamate Receptor 5 Market Challenges
Table 197. Metabotropic Glutamate Receptor 5 Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Metabotropic Glutamate Receptor 5 Product Picture
Figure 2. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Metabotropic Glutamate Receptor 5 Market Share by Type in 2024 & 2034
Figure 4. Alloswitch-1 Product Picture
Figure 5. BMS-952048 Product Picture
Figure 6. BMS-955829 Product Picture
Figure 7. Dipraglurant ER Product Picture
Figure 8. Others Product Picture
Figure 9. Global Metabotropic Glutamate Receptor 5 Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Metabotropic Glutamate Receptor 5 Market Share by Application in 2024 & 2034
Figure 11. Major Depressive Disorder
Figure 12. Alcohol Addiction
Figure 13. Alzheimer's Disease
Figure 14. Others
Figure 15. Metabotropic Glutamate Receptor 5 Report Years Considered
Figure 16. Global Metabotropic Glutamate Receptor 5 Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Metabotropic Glutamate Receptor 5 Revenue 2018-2034 (US$ Million)
Figure 18. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 19. Global Metabotropic Glutamate Receptor 5 Sales Quantity 2018-2034 (K Pcs)
Figure 20. Global Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Region (2018-2023)
Figure 21. Global Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Region (2024-2034)
Figure 22. North America Metabotropic Glutamate Receptor 5 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 23. North America Metabotropic Glutamate Receptor 5 Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Metabotropic Glutamate Receptor 5 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. Europe Metabotropic Glutamate Receptor 5 Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Metabotropic Glutamate Receptor 5 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. China Metabotropic Glutamate Receptor 5 Revenue YoY (2018-2034) & (US$ Million)
Figure 28. APAC Metabotropic Glutamate Receptor 5 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. APAC Metabotropic Glutamate Receptor 5 Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 31. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Top 10 and Top 5 Players Market Share by Metabotropic Glutamate Receptor 5 Sales Quantity in 2024
Figure 33. The Top 10 and Top 5 Players Market Share by Metabotropic Glutamate Receptor 5 Revenue in 2024
Figure 34. Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 35. Global Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Type (2018-2034)
Figure 36. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2018-2034)
Figure 37. Global Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Application (2018-2034)
Figure 38. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2018-2034)
Figure 39. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Company in 2024
Figure 40. North America Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Company in 2024
Figure 41. North America Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Type (2018-2034)
Figure 42. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2018-2034)
Figure 43. North America Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Application (2018-2034)
Figure 44. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2018-2034)
Figure 45. North America Metabotropic Glutamate Receptor 5 Revenue Share by Country (2018-2034)
Figure 46. North America Metabotropic Glutamate Receptor 5 Sales Quantity Share by Country (2018-2034)
Figure 47. U.S. Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 48. Canada Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 49. Europe Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Company in 2024
Figure 50. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Company in 2024
Figure 51. Europe Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Type (2018-2034)
Figure 52. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2018-2034)
Figure 53. Europe Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Application (2018-2034)
Figure 54. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2018-2034)
Figure 55. Europe Metabotropic Glutamate Receptor 5 Revenue Share by Country (2018-2034)
Figure 56. Europe Metabotropic Glutamate Receptor 5 Sales Quantity Share by Country (2018-2034)
Figure 57. Germany Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 58. France Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 59. U.K. Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 60. Italy Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 61. Russia Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 62. China Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Company in 2024
Figure 63. China Metabotropic Glutamate Receptor 5 Revenue Market Share by Company in 2024
Figure 64. China Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Type (2018-2034)
Figure 65. China Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2018-2034)
Figure 66. China Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Application (2018-2034)
Figure 67. China Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2018-2034)
Figure 68. APAC Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Company in 2024
Figure 69. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Company in 2024
Figure 70. APAC Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Type (2018-2034)
Figure 71. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2018-2034)
Figure 72. APAC Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Application (2018-2034)
Figure 73. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2018-2034)
Figure 74. APAC Metabotropic Glutamate Receptor 5 Revenue Share by Region (2018-2034)
Figure 75. APAC Metabotropic Glutamate Receptor 5 Sales Quantity Share by Region (2018-2034)
Figure 76. Japan Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 77. South Korea Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 78. China Taiwan Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 79. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 80. India Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 81. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Sales Quantity Share by Country (2018-2034)
Figure 88. Middle East, Africa and Latin America Metabotropic Glutamate Receptor 5 Revenue Share by Country (2018-2034)
Figure 89. Brazil Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 90. Mexico Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 91. Turkey Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 92. Israel Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 93. GCC Countries Metabotropic Glutamate Receptor 5 Revenue (2018-2034) & (US$ Million)
Figure 94. Metabotropic Glutamate Receptor 5 Value Chain
Figure 95. Metabotropic Glutamate Receptor 5 Production Process
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries